Answers are grounded in this paper and cite their sources.
In this systematic review, older age, asparaginase formulation, higher ALL risk stratification, and higher asparaginase dosing appear to play a limited role in the development of AAP. Further studies are needed to probe the underlying mechanisms contributing to the development of pancreatitis in patients receiving asparaginase.
No takes yet. Share an insight, caveat, or question.
Oparaji et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: